Skip Navigation

International Health

Tackling Antimicrobial Resistance

Dr. Anthony So talks to Politico about how to prevent drug-resistance bacteria 

Antimicrobial resistance (AMR) is an emerging health issue across the globe, as bacterial strains become resistant to the antibiotics meant to protect against them. In November 2015, it was discovered that a new form of resistance had developed against colistin, an antibacterial agent and the last-line of defense for warding off potentially deadly infections.  

Politico asks Dr. Anthony So how to protect our medicine from
bacteria developing resistance to antibiotics 

If left unchecked, it is projected that 10 million people will die from drug-resistant infections in 2050, more than the number of people who die from cancer annually today.

Politico recently asked Dr. Anthony So, a professor of the practice in International Health at the Bloomberg School, to give his assessment of the current situation and what he believes needs to be done now to prevent this future health threat. The founding director of the Innovation+Design Enabling Access (IDEA) Initiative, Dr. Anthony So, leads initiatives that tackle the growing issue of antimicrobial resistance. Joining the Health Systems Program in the Department of International Health in September 2016, Dr. So is also thematic lead for the Transformative Technologies and Institutions arm of the recently launched Johns Hopkins Alliance for a Healthier World. In addition to his work on antimicrobial resistance, Dr. So brings expertise in designing new technologies for greater health access to the Bloomberg School.    

Dr. So heads the Strategic Policy Program and North American team of ReAct—Action on Antibiotic Resistance, an independent international network dedicated to raising policy maker and public awareness about antibiotic resistance. ReAct North America also supports the work of the Antibiotic Resistance Coalition (ARC), a group of civil society organizations working in human, environmental and agricultural health advocating for global action on AMR.

Read more about Dr. So’s work with ReAct, and why it is important now to address antimicrobial resistance in order to avert the human and economic toll it will pose. 

February 23, 2018